No Data
No Data
European Equities Traded in the US as American Depositary Move Higher in Monday Trading
Trinity Biotech Secures Nasdaq Compliance, Eyes Growth
Express News | Trinity Biotech Regains Compliance With Nasdaq Listing Requirements
Trinity Biotech Acquires 12.5% Stake in Novus Diagnostics Valued at $2.5M
Express News | Trinity Biotech Shares Are Trading Higher After the Company Announced the Acquisition of EpiCapture. Also the Company Announced a Strategic Investment in Novus Diagnostics to Advance Development and Commercialization of Novus' Point-of-care Diagnostic...
Trinity Biotech Announces Acquisition Of Prostate Cancer Focused EpiCapture For Initial Consideration Of ~$3M, With An Additional Consideration Of $0.5M Contingent On The Achievement Of Future Milestones